IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v40y2017i2d10.1007_s40264-016-0478-x.html
   My bibliography  Save this article

Should Domperidone be Used as a Galactagogue? Possible Safety Implications for Mother and Child

Author

Listed:
  • Luc M. Hondeghem

    (HPC n.v. Pharmacology)

  • Noël H. Logghe

Abstract

Domperidone has been used as a galactagogue; however, solid evidence from an adequate sized randomized clinical trial is missing. Optimal dosage, start of treatment, length of treatment and scope of patients who can benefit also remain unknown. Although milk obtained after domperidone administration has not been shown to have untoward effects on newborns, no sufficiently large randomized clinical trial has been done to establish safety. Domperidone has repeatedly been shown to produce sudden cardiac death, starting at 30 mg/day. Because of this known cardiac effect, the use of domperidone to increase breast milk production may not be justified.

Suggested Citation

  • Luc M. Hondeghem & Noël H. Logghe, 2017. "Should Domperidone be Used as a Galactagogue? Possible Safety Implications for Mother and Child," Drug Safety, Springer, vol. 40(2), pages 109-113, February.
    • Handle: RePEc:spr:drugsa:v:40:y:2017:i:2:d:10.1007_s40264-016-0478-x
    DOI: 10.1007/s40264-016-0478-x
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-016-0478-x
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-016-0478-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:40:y:2017:i:2:d:10.1007_s40264-016-0478-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.